This former standalone prevention-status page has been folded into ASCVD / Lp(a) Prevention Master. It remains as a short preserved pointer so old links do not break.
cardiovascular · prevention-status · lp(a) · archived
This page is no longer the active owner. Its primary-vs-secondary prevention boundary, CAC/CCTA risk-tier table, LDL/ApoB target logic, and aspirin boundary were folded into ASCVD / Lp(a) Prevention Master on 2026-05-10.
Preserved core rule, updated after old papers were found: 2024 RPPH Doppler documents mild right common-femoral plaque/PAD (24-31% stenosis), so the profile is not risk-factor-only anymore; coronary/valve burden still requires CAC/CCTA/echo staging. Lp(a) this high plus peripheral plaque justifies aggressive risk-factor control and cardiology prevention review, but still not self-directed aspirin while GI bleeding risk is live.
Full original text is preserved in archive/ascvd-lpa-prevention-originals-2026-05-10.md.